From patterns to patients
What can we tell people with newly diagnosed epilepsy?
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published May 9, 2012.
Article Versions
- Previous version (May 9, 2012 - 13:02).
- You are viewing the most recent version of this article.
Author Disclosures
- Patricia E. Penovich, MD and
- Michael Gruenthal, MD, PhD
- Patricia E. Penovich, MD and
UCB Pharmaceutical Company Speakers’ Bureaus: Glaxo Smith Kline Pharmaceutical Company UCB Pharmaceutical Company
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1 Novartis 2 Sunovian 3 Lundbeck 4 UCB 5 SK Life Science
NONE
NONE
1. Tuberous Sclerosis Alliance
NONE
NONE
NONE
NONE
NONE
NONE
- Michael Gruenthal, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
New York State Department of Health.
NONE
NONE
NONE
1. Eisai 2. Sunovion 3. Upsher-Smith
NONE
NONE
NONE
NONE
NONE
Computer software, Apple Inc, 2011-12
NONE
NONE
NONE
- From the Minnesota Epilepsy Group PA (P.E.P.); Department of Neurology (P.E.P.), University of Minnesota School of Medicine, St Paul; Department of Neurology (M.G.), Albany Medical College; and Neurosciences Institute (M.G.), Albany Medical Center, Albany, NY.
- Correspondence & reprint requests to Dr. Penovich: ppenovich{at}mnepilepsy.net
Article usage
Cited By...
Letters: Rapid online correspondence
- What can we tell our patients
- Vesper Fe Marie L Ramos, Resident, University of Nebraska Medical Centervesper.ramos@yahoo.com
Submitted June 04, 2012
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Patterns of treatment response in newly diagnosed epilepsyM.J. Brodie, S.J.E. Barry, G.A. Bamagous et al.Neurology, May 09, 2012 -
Articles
Current treatments of epilepsySiddhartha Nadkarni, Josiane LaJoie, Orrin Devinsky et al.Neurology, June 27, 2005 -
Article
Patterns and prognostic markers for treatment response in generalized epilepsiesJoanna Gesche, Helle Hjalgrim, Guido Rubboli et al.Neurology, August 14, 2020 -
Articles
Comparative efficacy of combination drug therapy in refractory epilepsyNicholas P. Poolos, Lindsay N. Warner, Sophia Z. Humphreys et al.Neurology, December 14, 2011